White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effectiveness of CTX001 for Children with Severe Sickle Cell Disease Using Exagamglogene Autotemcel, Busulfan, and Plerixafor

Recruiting

3 1 1 1
Investigated Diseases:
- Sickle cell anaemia
Investigated Drugs:
Study on the Effects of Rivaroxaban in Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

Recruiting

3 1 1 1
Investigated Diseases:
- Short-bowel syndrome
Investigated Drugs:
- Rivaroxaban
Study on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study

Recruiting

3 1 1 1
Investigated Drugs:
- Ocrelizumab
Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Fianlimab
- Cemiplimab
Study on the Effects of Rituximab and Obinutuzumab in Patients with Systemic Lupus Erythematosus (SLE)

Recruiting

3 1 1 1
Investigated Diseases:
- Systemic lupus erythematosus
Investigated Drugs:
- Obinutuzumab
- Rituximab
Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

Recruiting

2 1 1 1
Investigated Diseases:
- Attention deficit hyperactivity disorder
- Type 1 diabetes mellitus
Investigated Drugs:
- Lisdexamfetamine Dimesylate
- Methylphenidate Hydrochloride
Study on the Safety of Faster Infusions for Cancer Patients Using Trastuzumab, Bevacizumab, and Atezolizumab

Recruiting

3 1 1 1
Investigated Diseases:
- Inflammatory bowel disease
- Rheumatic disorder
Investigated Drugs:
Study on Indocyanine Green for Evaluating Blood Flow in Surgery for Women with Recurrent or Persistent Gynecological Cancer

Recruiting

2 1 1 1
Investigated Drugs:
- Indocyanine Green
Study on the Effect of Lutropin Alfa to Improve Ovarian Reserve in Patients Undergoing IVF/ICSI Due to Tubal, Male Factor, or Unexplained Infertility

Recruiting

2 1 1 1
Investigated Drugs:
- Lutropin Alfa
Study on Cemiplimab for Patients with High-Risk Stage III/IV Cutaneous Squamous Cell Carcinoma

Recruiting

2 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of skin
Investigated Drugs:
- Cemiplimab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies